Actively Recruiting
A Research Registry on Aggressive PitNETs
Led by Hospices Civils de Lyon · Updated on 2023-08-08
200
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are studying aggressive pituitary tumors through a national research registry called HYPOcare, which gathers patient information from a multidisciplinary consultation meeting. This meeting brings together experts from across the country to help guide patient care and collect one of the largest cohorts of patients with aggressive pituitary tumors both nationally and internationally. Currently, the data is used only for clinical management and not for research purposes. The study involves adult patients with pituitary tumors whose medical files have been reviewed by the HYPOcare consultation meeting. There is a single group of participants, and the study is observational, meaning no new treatments or interventions are given as part of the trial. The registry collects clinical data to support research on the characteristics of aggressive pituitary tumors. Participants provide their medical information for analysis, and researchers will study the aggressiveness of the tumors using transcriptome analysis over a three-year period. No experimental treatments are administered, and no direct patient visits or interventions are required as part of this observational research. The study aims to improve understanding and future management of aggressive pituitary tumors through data collection and analysis.
CONDITIONS
Brief Title
A Research Registry on Aggressive PitNETs
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with a diagnosis of pituitary tumour
- Patients whose file has been presented to the national HYPOcare RCP
You will not qualify if you...
- Patients objecting to participating in this research
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 3 years
Participants with pituitary tumours are observed to characterize tumor aggressiveness over time through transcriptome analysis.
Visits scheduled as per clinical care and research assessments
Trial Site Locations
Total: 1 location
1
Hospices Civils de Lyon - Groupement Hospitalier Est
Lyon, France, 69003
Actively Recruiting
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here